COMPANY:

Canexia Health

"Imagia Canexia Health...announced that Health Canada now permits ICHIP—held under ICH’s Imagia Healthcare subsidiary—to be manufactured and deployed across Canada...The ICHIP furthers their ability by providing intricate molecular and computational genome analysis, from targeted next-generation sequencing (NGS) data, for individual cancer patients. This new approval advances Imagia Canexia Health’s mission to combine groundbreaking genomics, oncology, artificial intelligence, and informatics so health systems can provide cost-effective testing in-house."

"Precision oncology firm Imagia Canexia Health and Saudi Arabian diagnostic firm Anwa Medical said Thursday that they have partnered to bring distributed liquid biopsy testing products first into Saudi Arabia and eventually to the larger Middle East and North Africa region...The companies said the partnership will leverage Imagia Canexia Health's AI capabilities to support local, in-house precision oncology solutions, with the initial foray in Saudi Arabia supporting the development of domestic precision oncology and genomics expertise and the infrastructure necessary for future development."

"Imagia Canexia Health...announced the CE-IVD marking for its Imagia Canexia Health Insights Platform (ICHIP) to operate across Europe. ICHIP provides intricate molecular and computational genome analysis, from targeted next-generation sequencing (NGS) data, for individual cancer patients. The company offers a unique clinical solution for European oncologists to quickly generate reports—including therapeutic and clinical trial recommendations."

"Imagia Cybernetics...announced its merger with Canexia Health...Aligning resources, the merger now enables expanded access to precision-guided cancer management. Imagia's robust data insights technology preserves cancer healthcare data privacy via federated learning and Canexia's end-to-end solution tests, validates, and delivers the analysis directly to the oncologist."